Week In Review: WuXi PharmaTech To List Subsidiary On China’
Deals and Financings WuXi PharmaTech (NYSE: WX), China’s largest CRO/CMO, has filed to list its chemical manufacturing subsidiary, SynTheAll Pharmaceutical Co. Ltd., on China’s Third Board, a two-year old electronic OTC exchange (see story). Although it has submitted a listing application, WuXi said it may not conduct an IPO for STA immediately after approval. WuXi further explained…